VERAXA Biotech

Heidelberg, Germany

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.

Jun 2026

Post-IPO Equity

Biotechnology Financial Exchanges Financial Services Health Care Medical

Top Investors

Lincoln Park Capital Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about VERAXA Biotech

Who are VERAXA Biotech's investors?

VERAXA Biotech's investors include Lincoln Park Capital Fund.

Where is VERAXA Biotech headquartered?

VERAXA Biotech is headquartered in Heidelberg, Germany.

What does VERAXA Biotech do?

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.

What stage is VERAXA Biotech at?

VERAXA Biotech is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 10, 2026.

MLA

"VERAXA Biotech — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/veraxa-biotech. Accessed June 30, 2026.

APA

VCBacked. (2026). VERAXA Biotech — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/veraxa-biotech

Wikipedia (cite web)

{{cite web |title=VERAXA Biotech — Funding & Investors |url=https://www.vcbacked.co/company/veraxa-biotech |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 10, 2026.

Similar Companies in Biotechnology